JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 83 filers reported holding JOUNCE THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 1.59 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $152,000 | -25.5% | 30,675 | -6.7% | 0.00% | -100.0% |
| Q1 2019 | $204,000 | +68.6% | 32,875 | -8.4% | 0.00% | – |
| Q4 2018 | $121,000 | -51.0% | 35,875 | -5.5% | 0.00% | -100.0% |
| Q3 2018 | $247,000 | -19.0% | 37,975 | -4.7% | 0.00% | 0.0% |
| Q2 2018 | $305,000 | -65.0% | 39,839 | +2.1% | 0.00% | -50.0% |
| Q1 2018 | $872,000 | +84.4% | 39,007 | +5.1% | 0.00% | +100.0% |
| Q4 2017 | $473,000 | – | 37,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|